Viewing Compound With Targets


Compound Report Overview

Compound Name: TA-270
Compound Identifier: 704173
Mol Structure 2D: 704173
Molecular Weight: 525
Formula: C29 H36 N2 O7
Development Status: Clinical Phase I
SMILES: CCCCCCCCOc1c(O)c2ccc(NC(O)CCc3cc(OC)c(O)c(OC)c3)cc2n(C)c1O
Compound Targets